Moreover, improving healthcare infrastructure in emerging economies such as China and India, and
increasing research and development activities are contributing towards the growth of anti-thrombin market
in Asia Pacific region.
New Product Launch & Innovations Play Vital Role in Anti-thrombin Market
Key players implement various strategies to establish their footprint in the global market, thereby enhancing
their sale and outreaching the customers. For instance, in April 2014, Revo Biologics started preserve – 1
phase III clinical trials of ATryn (recombinant antithrombin) for treatment of preeclampsia in pregnant
women during 24th to 28th weeks of pregnancy.
Key player’s profiles in the report areGrifols, Shire Plc., rEVO Biologics Inc., CSL Limited, Kedrion S.p.A,
Lee Bisolutions, Scripps Laboratories Inc., GTC Biotherapeutics, Inc.’s, Green Cross Corp., and BDI
Pharma, and among others.
Download free sample report at https://precisionbusinessinsights.com/request-sample?product_id=19020
Detailed Segmentation
By Source Type
o
o
o
Goat Milk
Human
Others
By Application Type
o
o
o
Diagnostics
Therapeutics
Research
By Dosage Form
o
o
Liquid
Lyophilized
By End-User Type
o
o
o
Blood Banks
Diagnostic Centres
Hospitals
Geography
o
o
North America
U.S.
Canada
Europe